Adipose-derived SVF for Treatment of Alopecia

Exclusion Criteria

• •1. History of bleeding disorders, anticoagulation therapy that cannot be stopped 14 days prior to injection
• •2. Allergic to lidocaine, epinephrine, valium or sodium phosphate
• •3. Individuals with a propensity for keloids
• •4. Individuals with diminished decision-making capacity will not be included in this research study
• •5. Current use of anti-inflammatory or anticoagulation medications that affect bleeding or are for bleeding disorders. These include: Plavix, Warfarin (Coumadin, Jantoven, Marfarin). In addition, if any of the following medicines are used two (2) weeks prior to surgery the patient will be ineligible.
• •6. Use of concomitant treatments, including topical medications, oral medications, meso-therapy, non-ablative fractional laser treatment, low-level laser therapy, interfollicular PRP injection and hair transplantation within the preceding 6 months.
• •7. All smokers and other tobacco users.